Clinical trials
Completed Myelodysplastic Syndromes trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
84 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 4 |
| 2005 | 3 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 10 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 8 |
| 2014 | 6 |
| 2015 | 6 |
| 2016 | 11 |
| 2017 | 5 |
| 2018 | 4 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 84 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Groupe Francophone des Myelodysplasies | 13 |
| Celgene | 10 |
| Novartis Pharmaceuticals | 6 |
| Institut Paoli-Calmettes | 5 |
| European Organisation for Research and Treatment of Cancer - EORTC | 4 |
| Traws Pharma, Inc. | 4 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Astex Pharmaceuticals, Inc. | 2 |
| Celgene Corporation | 2 |
| Institut de Recherches Internationales Servier | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 84 |
| Leukemia, Myeloid, Acute | 38 |
| Leukemia, Myelomonocytic, Chronic | 18 |
| Anemia | 8 |
| Leukemia | 8 |
| Anemia, Refractory, with Excess of Blasts | 6 |
| Bone Marrow Diseases | 5 |
| Hematologic Neoplasms | 5 |
| Myeloproliferative Disorders | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
Trials
Showing 1 to 25 of 84. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.